These findings suggest that Smyd3 could be a general regulator of Shcbp1, leading to the dynamics of increase of H3K4me3 and Smyd3 activation in both BRCA–/− and parous mammary epithelial cells in premalignant stages and general tumor progression process. This evidence concerns the gene SMYD3 and neoplasm.